Carnosine and Lung Disease.

Area of Science:

• Biochemistry
• Physiology
• Pharmacology

Background:

• Carnosine (β-alanyl-L-histidine) is a dipeptide known for antioxidant, metal chelation, and buffering properties.
• Traditionally studied in high-carnosine organs (muscle, brain), recent research investigates its role in low-carnosine tissues like the lung.
• Oxidative stress is implicated in lung diseases, making carnosine's antioxidant capacity a focus for therapeutic potential.

Purpose of the Study:

• To review the in vitro and in vivo biological actions of carnosine.
• To discuss the role and protective mechanisms of carnosine in organs with low carnosine levels, particularly the lung.
• To highlight carnosine's potential in treating lung conditions such as acute lung injury and pulmonary fibrosis.

Main Methods:

• Literature review of carnosine's biological and physiological actions.
• Analysis of studies investigating carnosine supplementation in animal models of lung injury and fibrosis.
• Examination of in vitro and in vivo data on carnosine's protective effects.

Main Results:

• Carnosine exhibits significant antioxidant, anti-glycation, and anti-carbonylation activities.
• Supplementation with carnosine demonstrated protective effects in animal models of acute lung injury and pulmonary fibrosis.
• Evidence suggests carnosine's antioxidant properties are key to its lung-protective mechanisms.

Conclusions:

• Carnosine possesses multifaceted protective properties relevant to lung health.
• Its antioxidant effects are particularly promising for therapeutic interventions in lung diseases.
• Further research into carnosine and related compounds could lead to novel treatments for pulmonary conditions.